Research map: Clinical characteristics and outcomes of liver transplant recipients with carbapenem resistant klebsiella pneumonia infection

Back to the article

Papers in this map

  1. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting · Teresa C Horan · 2008 · 6713 citations · Cited by this paper
  2. Functional analyses of male-specific early-phosphorylated proteins reveal an intrinsically disordered protein required for microgamete release in Plasmodium berghei · 2026 · Related
  3. Infection in Solid-Organ Transplant Recipients · Jay Alan Fishman · 2007 · 1949 citations · Cited by this paper
  4. Incremental diagnostic value of bloodstream pathogen ddPCR for early identification of blood culture-positive bloodstream infection · 2026 · Related
  5. Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition · Romney Humphries · 2021 · 1523 citations · Cited by this paper
  6. Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b · 2026 · Related
  7. Infections in liver transplant recipients · Fabián Andrés Rosas Romero · 2011 · 185 citations · Cited by this paper
  8. Cooperation of transposable elements to endow global networks of initiators of hybrid assembly pathways of endogenous multiprotein complexes · 2026 · Related
  9. Bacterial infection after liver transplantation · Sang-Il Kim · 2014 · 185 citations · Cited by this paper
  10. Longitudinal dynamics and treatment-associated determinants of interferon-gamma responses in tuberculosis: a 10-year retrospective QuantiFERON-TB Gold study · 2026 · Related
  11. Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors · Milo Gatti · 2021 · 60 citations · Cited by this paper
  12. Diagnostic and differential diagnostic value of plasma extracellular vesicle-associated miRNAs in AIDS patients with tuberculosis and non-tuberculous mycobacterial infection · 2026 · Related
  13. Bilirubin Impairs Bactericidal Activity of Neutrophils through an Antioxidant Mechanism in Vitro · Toshiyuki Arai · 2001 · 57 citations · Cited by this paper
  14. Lipid metabolism in the resuscitation of dormant mycobacterium tuberculosis: molecular resilience, host hijacking, and clinical opportunities · 2026 · Related
  15. Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study · Guanhao Zheng · 2021 · 49 citations · Cited by this paper
  16. Admission CD4+ T cell BTLA expression and its association with infection risk and respiratory outcomes in sepsis · 2026 · Related
  17. High prevalence of multidrug-resistant gram-negative bacterial infection following pediatric liver transplantation · Chanita Phichaphop · 2020 · 37 citations · Cited by this paper
  18. Prevalence and genetic diversity of respiratory syncytial viruses circulating in Bulgaria, 2023-2025 · 2026 · Related
  19. Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients · Francesco Barchiesi · 2016 · 36 citations · Cited by this paper
  20. Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study · Guanhao Zheng · 2022 · 36 citations · Cited by this paper
  21. A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting · Abdullah Tarık Aslan · 2022 · 35 citations · Cited by this paper
  22. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae · Elena Pérez‐Nadales · 2023 · 33 citations · Cited by this paper
  23. Ceftazidime-Avibactam as Salvage Treatment for Infections Due to Carbapenem-Resistant Klebsiella pneumoniae in Liver Transplantation Recipients · Fang Chen · 2021 · 28 citations · Cited by this paper
  24. Efficacy of Ceftazidime-Avibactam in the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection After Kidney Transplantation · Fei Zhang · 2021 · 21 citations · Cited by this paper
  25. The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations · Stelios F. Assimakopoulos · 2024 · 20 citations · Cited by this paper
  26. High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction · Fangfang Chen · 2020 · 19 citations · Cited by this paper
  27. Epidemic, risk factors of carbapenem-resistant Klebsiella pneumoniae infection and its effect on the early prognosis of liver transplantation · Ning Liu · 2022 · 19 citations · Cited by this paper
  28. Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients · Xiaoxia Wu · 2022 · 17 citations · Cited by this paper
  29. Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients · Jingli Lü · 2022 · 13 citations · Cited by this paper
  30. Clinical outcomes associated with carbapenem resistant Klebsiella pneumoniae (CRKP) in abdominal solid organ transplant (SOT) recipients · Tiffany E. Bias · 2017 · 12 citations · Cited by this paper
  31. Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections: Focus on solid organ transplantation recipients · Juan Hu · 2024 · 12 citations · Cited by this paper
  32. Clinical outcomes and risk factors for mortality in recipients with carbapenem-resistant gram-negative bacilli infections after kidney transplantation treated with ceftazidime-avibactam: a retrospective study · Fei Zhang · 2024 · 10 citations · Cited by this paper
  33. Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem · Zhiqiang Wang · 2021 · 8 citations · Cited by this paper
  34. Effect of Carbapenem-Resistant Klebsiella pneumoniae Infection on the Clinical Outcomes of Kidney Transplant Recipients · Mengmeng Zheng · 2022 · 8 citations · Cited by this paper
  35. Klebsiella pneumoniae infections after liver transplantation: Drug resistance and distribution of pathogens, risk factors, and influence on outcomes · Long Guo · 2024 · 8 citations · Cited by this paper
  36. Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates · Tilman G. Schultze · 2021 · 7 citations · Cited by this paper
  37. Epidemiology, Drug Resistance, and Risk Factors for Mortality Among Hematopoietic Stem Cell Transplantation Recipients with Hospital-Acquired Klebsiella pneumoniae Infections: A Single-Center Retrospective Study from China · Yanfeng Liu · 2022 · 6 citations · Cited by this paper
  38. Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation · Yanfeng Liu · 2023 · 6 citations · Cited by this paper
  39. Carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation: Drug resistance, risk factors and impact on prognosis · Taohua Liu · 2025 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)